Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

• Status: Completed
• Trial end date: 2019-08-02
• Target enrollment: 0
• Participant gender: All

Summary

Our study included 60 patients with idiopathic OAB and treated with solifenacin 5mg twice daily for one month. After improvement of their condition, we divided the responders into 2 groups, group I stopped the drug suddenly, while group II underwent gradual weaning of the drug.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beni-Suef University
• Treatments: Cholinergic Antagonists; Solifenacin Succinate; Tin Fluorides

Criteria

Inclusion Criteria:

• OAB patients.

• Recently diagnosed.

Exclusion Criteria:

• Previous trials of treatment

• UTI, stones, tumors, or Infravesical obstruction.